checkAd

     154  0 Kommentare VYNE Therapeutics to Host Physician Symposium on AMZEEQ and ZILXI

    Live webinar on October 1st to feature presentations by 3 KOLs in dermatology

    BRIDGEWATER, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that the Company will host a physician symposium on AMZEEQ and ZILXI on Thursday, October 1, 2020 from 12pm – 3pm ET.

    The webinar will feature presentations by Key Opinion Leaders (KOLs) Ted Lain, M.D. (Sanova Dermatology), Julian Moore, FAAD (Hollywood Dermatology) and Linda Stein Gold, M.D. (Henry Ford Health System), who will discuss the current treatment landscape and unmet medical needs in treating patients with acne vulgaris and rosacea. Drs. Lain and Moore will discuss their experiences treating acne patients with AMZEEQ (minocycline) topical foam, 4% and Dr. Stein Gold will discuss ZILXI (minocycline) topical foam, 1.5% and her expectations of how the product will be used to treat rosacea patients in her practice. In addition, VYNE management will discuss the commercial progress and plans for these two products. There will be a Q&A session following the formal presentations.

    To register for the symposium, please click here.

    Ted Lain, MD is a board-certified Dermatologist and Chief Medical Officer specializing in diagnosis and treatment of disorders of the hair, skin and nails. He also specializes in minimally-invasive cosmetic and laser skin rejuvenation procedures. Dr. Lain is a Physician Trainer for Allergan whereby he trains other physicians and medical professionals how to correctly and safely inject BOTOX Cosmetic, JUVÉDERM, and JUVÉDERM VOLUMA. After graduating with highest honors from the University of Texas he obtained his joint medical/masters in business administration degrees from Baylor College of Medicine and Rice University in Houston, Texas. He moved to Little Rock, Arkansas where he completed his internship in Internal Medicine and his specialized training in Dermatology.

    Julian O’Neil Moore, FAAD is a board-certified dermatologist at Hollywood Dermatology and Cosmetic Surgery Specialists in Hollywood, Florida and the Assistant Director of the Larkin/Nova Southeastern University Dermatology Residency Training Program. Dr. Moore specializes in skin conditions, such as acne, eczema and psoriasis, as well as skin cancer detection and treatment. He also treats conditions affecting the hair and nails. Dr. Moore received his undergraduate degree in Biology with honors from the State University of New York at Stony Brook Health Sciences Center. He received his Doctorate in Medicine from the New York College of Osteopathic Medicine in 2001 followed by a medical internship at St. Barnabas Hospital in the Bronx, New York. Dr. Moore later completed his Post-Doctoral NIH Fellowship in Dermatology and Cutaneous Malignancy at Mount Sinai Icahn School of Medicine in both the Department of Dermatology and Department of Radiation Oncology in New York City. Dr. Moore completed his residency in Dermatology at Nova Southeastern University / Broward General Medical Center Fort Lauderdale. 

    Seite 1 von 5



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    VYNE Therapeutics to Host Physician Symposium on AMZEEQ and ZILXI Live webinar on October 1st to feature presentations by 3 KOLs in dermatologyBRIDGEWATER, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) - VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that the Company will host a …